The inv dup (15) or idic (15) syndrome (Tetrasomy 15q) by Battaglia, Agatino
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Orphanet Journal of Rare Diseases
Open Access Review
The inv dup (15) or idic (15) syndrome (Tetrasomy 15q)
Agatino Battaglia
Address: Stella Maris Clinical Research Institute for Child and Adolescent Neurology and Psychiatry, Calambrone, Pisa, Italy
Email: Agatino Battaglia - abattaglia@inpe.unipi.it
Abstract
The inv dup(15) or idic(15) syndrome displays distinctive clinical findings represented by early
central hypotonia, developmental delay and intellectual disability, epilepsy, and autistic behaviour.
Incidence at birth is estimated at 1 in 30,000 with a sex ratio of almost 1:1. Developmental delay
and intellectual disability affect all individuals with inv dup(15) and are usually moderate to
profound. Expressive language is absent or very poor and often echolalic. Comprehension is very
limited and contextual. Intention to communicate is absent or very limited. The distinct behavioral
disorder shown by children and adolescents has been widely described as autistic or autistic-like.
Epilepsy with a wide variety of seizure types can occur in these individuals, with onset between 6
months and 9 years. Various EEG abnormalities have been described. Muscle hypotonia is observed
in almost all individuals, associated, in most of them, with joint hyperextensibility and drooling.
Facial dysmorphic features are absent or subtle, and major malformations are rare. Feeding
difficulties are reported in the newborn period.
Chromosome region 15q11q13, known for its instability, is highly susceptible to clinically relevant
genomic rearrangements, such as supernumerary marker chromosomes formed by the inverted
duplication of proximal chromosome 15. Inv dup(15) results in tetrasomy 15p and partial tetrasomy
15q. The large rearrangements, containing the Prader-Willi/Angelman syndrome critical region
(PWS/ASCR), are responsible for the inv dup(15) or idic(15) syndrome. Diagnosis is achieved by
standard cytogenetics and FISH analysis, using probes both from proximal chromosome 15 and
from the PWS/ASCR. Microsatellite analysis on parental DNA or methylation analysis on the
proband DNA, are also needed to detect the parent-of-origin of the inv dup(15) chromosome.
Array CGH has been shown to provide a powerful approach for identifying and detecting the
extent of the duplication. The possible occurrence of double supernumerary isodicentric
chromosomes derived from chromosome 15, resulting in partial hexasomy of the maternally
inherited PWS/ASCR, should be considered in the differential diagnosis. Large idic(15) are nearly
always sporadic. Antenatal diagnosis is possible. Management of inv dup(15) includes a
comprehensive neurophysiologic and developmental evaluation. Survival is not significantly
reduced.
Disease name and synonyms: The inv dup(15) or idic(15) syndrome can also be termed
"tetrasomy 15q". About 160 patients have been reported in the medical literature [1-5].
Published: 19 November 2008
Orphanet Journal of Rare Diseases 2008, 3:30 doi:10.1186/1750-1172-3-30
Received: 20 March 2008
Accepted: 19 November 2008
This article is available from: http://www.ojrd.com/content/3/1/30
© 2008 Battaglia; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Orphanet Journal of Rare Diseases 2008, 3:30 http://www.ojrd.com/content/3/1/30
Page 2 of 7
(page number not for citation purposes)
Background
The inv dup(15) or idic(15) syndrome (inverted duplica-
tion of proximal chromosome 15 or isodicentric 15 chro-
mosome) displays distinctive clinical findings represented
by early central hypotonia, developmental delay and
intellectual disability, epilepsy, and autistic behavior. The
latter is characterized by lack of social interaction, non-
functional use of objects, primordial type of exploration,
stereotypies, absent or very poor echolalic language, lim-
ited comprehension, and poor intention to communicate.
Physically, there are only minor anomalies. Altogether,
this picture constitutes a distinct and recognizable neuro-
genetic disorder, that can be suspected clinically, even
before the cytogenetic confirmation.
Many rearrangements may occur in the imprinted chro-
mosome region 15q11q13, which is known for its insta-
bility [6] due to the presence of repeated DNA elements
[7,8]. The rearrangements include deletions associated
either with Angelman syndrome (AS) or with Prader-Willi
syndrome (PWS), according to parental origin [9]; trans-
locations, inversions and supernumerary marker chromo-
somes formed by the inverted duplication of proximal
chromosome 15. Interstitial duplications, triplications
and balanced reciprocal translocations are much less fre-
quent [10]. The inv dup (15) or idic (15) is the most com-
mon of the heterogeneous group of the extra structurally
abnormal chromosomes (ESACs). Two cytogenetic types
of inv dup (15) marker chromosomes have been identi-
fied, with different phenotypic consequences [11-14].
One is a metacentric or submetacentric and heterochro-
matic chromosome, smaller or similar to a G group chro-
mosome, not containing the PWS/AS critical region
(PWS/ASCR), and the cytogenetic description is
dic(15)(q11). dic(15)(q11) can be familial or de novo, and
is the most common ESAC accounting for about 70% of
all small extra marker chromosomes. Most children with
this aberration show a normal phenotype [15], although
exceptions have been recorded [16]. The second type of
inv dup (15) is as large as, or larger than, a G group chro-
mosome and has 15q euchromatin. It includes the PWS/
ASCR [17,18], and the cytogenetic description is
dic(15)(q12 or q13). The vast majority of dic(15)(q12 or
q13) derives from the two homologous maternal chromo-
somes at meiosis, and is reportedly associated with
increased mean maternal age at conception, similar to
other aneuploides. The presence of large inv dup (15)
results in tetrasomy 15p and partial tetrasomy 15q. How-
ever, considerable structure heterogeneity has recently
been described in a few patients [19]. This condition is
associated with an abnormal phenotype, which consti-
tutes the idic(15) syndrome [20,21]. In all such cases,
standard cytogenetics must be associated with FISH (fluo-
rescence in situ hybridization) analysis, using probes both
from proximal chromosome 15 and from the PWS/ASCR
[2,22]. Molecular studies, such as microsatellite analysis
on parental DNA or methylation analysis on the proband
DNA, are also needed in order to detect the parent-of-ori-
gin of the inv dup (15) chromosome [2,22]. Recently,
array CGH (array comparative genomic hybridization)
has been shown to provide a powerful approach to detect
the duplication and its extent [4].
Maternally derived cytogenetic mosaicism with a normal
cell line has been described in a small subset of individu-
als [23,24]. Recently, one patient with a mosaic paternally
derived inv dup(15), showing a mild PWS phenotype, has
been reported by Saitoh et al. [25].
Epidemiology
Although poorly known, incidence at birth is estimated to
be 1 in 30,000 with a sex ratio of almost 1 [3]. However,
a higher incidence is plausible due to under-ascertain-
ment. Since dysmorphic features are absent or subtle and
major malformations are rare, chromosome analysis may
not be thought to be indicated, and some individuals, par-
ticularly in the older age groups, probably remain undiag-
nosed.
Clinical description
Developmental delay and intellectual disability affect all
individuals with inv dup (15) and are usually moderate to
profound [1,2,13,17,21,26,27]. Age of acquisition of
motor milestones are seldom reported in the medical lit-
erature. However, it seems that sitting is achieved between
10 and 20 months of age, and walking between 2 and 3
years [17,21]. Expressive language is absent or very poor;
it is often echolalic with immediate and delayed echolalia
and pronoun reversal. Comprehension is very limited,
contextual and accompanied by the gesture. Intention to
communicate is absent or very poor [21,27]. The distinct
behavior disorder shown by children and adolescents has
been widely described as autistic or autistic-like. A strong
association between autistic features and isodicentric
chromosome 15 [idic (15)] was reported by Rineer et al.
[28]. The patients reported by Borgatti et al. [29] met the
clinical criteria for the diagnosis of autistic disorder by
DSM IV (Diagnostic and Statistical Manual – Revision 4).
Usually, these kids have gaze avoidance from very early
on; shun body contact; stare at people as looking through
them. They can be fascinated by certain sounds, by the
water, or by spinning or any glittering objects. They usu-
ally prefer being left alone, lying on the back just looking
at their fingers and taking bizarre postures. Symbolic play
is usually never acquired. They show no interest toward
their peers, and usually do not develop appropriate social
interactions. When thwarted, they can react with out-
bursts of shouting or with aggressiveness. Non-functional
use of objects with a primordial type of exploration is also
observed. Stereotypies are frequently seen, including handOrphanet Journal of Rare Diseases 2008, 3:30 http://www.ojrd.com/content/3/1/30
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flapping, hand-wringing, hand-clapping over plane sur-
faces, finger biting, head turning, spinning him/herself for
long periods of time. Hyperactivity has been reported in a
number of cases [21,26,27].
Epilepsy with a wide variety of seizures can occur in these
individuals, with onset between ages 6 months and 9
years [2,13,21,26,30]. Infantile spasms associated with an
hypsarrhythmic EEG (electroencephalogram) have been
reported in several patients [2,13,17,30]. Typical Lennox-
Gastaut syndrome or Lennox-Gastaut-like syndrome was
observed in the four inv dup (15) patients reported by
Battaglia et al. [21]. These had tonic/atonic (as head drops
or drop attacks), tonic-clonic seizures and atypical
absences with onset between 4 and 8 years of age. Seizures
were difficult to control in all, despite adequate antiepi-
leptic treatment. Difficult to control seizures, associated
with some degree of deterioration were also reported by
other authors [13,17,26,31]. Complex partial and myo-
clonic seizures were observed in a number of other indi-
viduals [26]. Drug-resistant myoclonic absence-like
seizures induced by emotionally gratifying stimuli (kiss-
ing, viewing of pleasant or funny events) have been
reported in a 9-year-old boy [32]. A mild, adult-onset,
generalized epilepsy with absence seizures and occasional
head drops, and generalized tonic-clonic seizures has also
been occasionally reported, with a good outcome [33].
Benign epilepsy with centro-temporal spikes with a
benign evolution has been observed in another inv
dup(15) individual [34].
In the medical literature, very little is reported on the EEG
characteristics in inv dup (15) syndrome, mainly due to
the poor description of these findings and a total lack of
serial EEG studies [2,13,26,27,30]. In 1997, Battaglia et al.
[21] described in detail the EEG abnormalities observed
in four such individuals. All received serial polygraphic-
video-EEG recordings during wakefulness and sleep (over-
night sleep in 2 of the 4) over a long period of time. All
EEGs were abnormal, showing: 1) slow background activ-
ity; 2) absence or poverty of the rhythmic activities usually
elicited over the posterior third of the brain, on eye clo-
sure; 3) multifocal discharges with variable hemispheric
predominance; 4) frequent, large amplitude, generalized
paroxysms, lasting 2 to 20 seconds, characterized by slow
sharp element-spike/wave complexes, mostly accompa-
nied by atypical absences; 5) frequent generalized bursts
of fast rhythms during slow wave sleep in 2 of the 4
patients, accompanied by tachypnea and/or by an upward
rotation of the eyes, and/or by tonic fits; 6) disruption of
the usual sleep structure. Other EEG findings reported in
the literature include generalized rhythmic 3.5–4 Hz
spike-and-wave discharges, lasting 4–6 seconds [33].
Additional EEG abnormalities consist of diffuse spikes,
polispikes, and ill-defined polispike/wave complexes,
with variable hemispheric predominance (Fig. 1) [per-
sonal observation].
Muscle hypotonia is observed in almost all individuals,
associated, in most of them, with joint hyperextensibility
and drooling. Other physical findings are rather unspe-
cific and may include: minor facial dysmorphisms, char-
acterized by downslanting palpebral fissures, epicanthal
folds, deep-set eyes, low-set and/or posteriorly rotated
ears, highly arched palate, broad nose, anteverted nares;
5th finger clinodactyly and unusual dermatoglyphics; par-
tial 2nd–3rd toe syndactyly [3,21]. Brachycephaly, frontal
bossing, synophrys, broad nose, short philtrum, cleft pal-
ate, prominent mandible in adults, brachydactyly, and
areas of increased and reduced skin pigmentation can be
occasionally observed. Major malformations, such as ven-
tricular septal defects, tetralogy of Fallot, unilateral renal
agenesis, umbilical and inguinal hernias, hypospadias,
cryptorchidism, and talipes seem to be rare
[13,17,18,21,35-38]. Feeding difficulties are reported in
the newborn period [5]. Growth is retarded in about
20%–30% of the patients. Microcephaly is observed in
less than 20% of individuals, while macrocephaly in less
than 3%. Hypogonadism is reported in about 20% [1,3].
Although puberty is reportedly normal in most individu-
als [39], pubertal disorders, such as central precocious
puberty or ovarian dysgenesis, have been observed in
three girls [40]. To the best of our knowledge, no individ-
ual with idic(15) syndrome is known to have reproduced.
Pregnancies and birth weights are mostly normal. Mean
parental/maternal ages at birth of the probands were
markedly advanced [2,41]. Brain neuroimaging (CT/MRI)
does not show abnormal findings in most cases [21,29].
Molecular characterization
Various genetic mechanisms have been hypothesized to
explain clinical heterogeneity, including the size of chro-
mosomal duplication, dosage effect of genes in this
region, and the imprinting mechanism.
The fact that tetrasomy of the PWS/ASCR is associated
with a more severe phenotype than the one observed in
trisomy, suggests that there is a dosage effect for a gene or
genes in this region [5,42]. Furthermore, gene expression
in this critical region is regulated by an imprinting mech-
anism [43]. Since only maternally inherited aberrations of
chromosome 15q11-13 seem to be pathogenic, with the
sole exception of one patient [44], it is likely that maternal
genes, contained in this genomic region, act in a dosage-
dependent manner and that their copy number is critical
for normal brain development and function. Five recur-
rent breakpoints (BP) have been described in most cases
and most idic(15) chromosomes arise through BP3:BP3
or BP4:BP5 recombination events (Fig. 2). The ~4Mb seg-Orphanet Journal of Rare Diseases 2008, 3:30 http://www.ojrd.com/content/3/1/30
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ment that encompasses the PWS/ASCR lies between BP2
and BP3. The most frequent form of idic (15) is character-
ized by an asymmetric recombination event between BP4
and BP5. This leads to tetrasomy for the interval from the
centromere to BP4 and to trisomy from BP4 to BP5 [4].
Amongst the genes that are known to be located at or near
the PWS/ASCR, an interesting relationship has been
shown between the α5 and β3 GABA (gamma-aminobu-
tyric acid) receptor subunit genes and the P gene. In fact,
even though these genes are not imprinted, a deletion of
both P alleles causes, in the mouse, rearrangements of α5
and β3 receptors producing a particular phenotype char-
acterized by seizures, jerky gait and ataxia [45]. Tetrasomy
of these genes, as seen in inv dup (15) syndrome, may
alter the GABA receptor activity, upon which the major
CNS (central nervous system) inhibitory mechanisms
Inv dup(15) or idic(15) patient at age 12 ys7 m Figure 1
Inv dup(15) or idic(15) patient at age 12 ys7 m. Slow wave sleep. EEG showing diffuse spikes, polispikes, ill-defined 
polispike/wave complexes, somewhat predominant over the right hemisphere. Amplitude 100 μV/cm; speed 1 sec/1.5 cm.
Schematic representation of chromosome 15, showing the five recurrent breakpoints (BP), and the ~4 Mb segment that  encompasses the PWS/AS critical region Figure 2
Schematic representation of chromosome 15, showing the five recurrent breakpoints (BP), and the ~4 Mb seg-
ment that encompasses the PWS/AS critical region.Orphanet Journal of Rare Diseases 2008, 3:30 http://www.ojrd.com/content/3/1/30
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rely. This alteration could represent the biological basis
for some clinical manifestations of the inv dup (15) syn-
drome individuals, such as seizures, hyperactivity, aggres-
siveness, and autistic disorder. Of interest, linkage
disequilibrium between a marker in the γ-aminobutiric
acidA receptor subunit gene, GABRB3 155CA-2, and autis-
tic disorder has been reported by Cook et al. [46]. An addi-
tional gene, located more distally, the SLC12A6 (solute
carrier, family 12, member 6), coding for a cation chloride
cotransporter and expressed in the brain, heart, skeletal
muscle, and kidney, could also potentially be implicated
in the pathogenesis of seizures [47].
A phenotype-genotype correlation has been attempted,
but it was problematic. In fact, component manifestations
such as seizure history, behaviour disorder, and develop-
mental status are difficult to assess accurately, especially
in young children, and there is also considerable variation
in the breakpoints [5, personal observation].
A recent study performed on post-mortem brain tissue
from two individuals with 15q11-13 hexasomy and
15q11-13 tetrasomy respectively, suggests that genetic
copy number variation, combined with additional genetic
or environmental influences on epigenetic mechanisms,
impact clinical heterogeneity and outcome of idic(15)
syndrome [48].
Diagnosis and diagnostic methods
Clinicians should suspect this syndrome in any infant or
child with early central hypotonia, minor dysmorphic fea-
tures, developmental delay/intellectual disability, autism
or autistic-like behavior, who subsequently develops hard
to control seizures/epilepsy (Table 1).
Standard cytogenetics (G-C-banding methods) must be
associated with FISH analysis, using probes both from
proximal chromosome 15 and from the PWS/ASCR
[2,22]. Molecular studies, such as microsatellite analysis
on parental DNA or methylation analysis on the proband
DNA, are also needed in order to detect the parent-of-ori-
gin of the inv dup (15) chromosome [2,22]. Recently,
array CGH has been shown to provide a powerful
approach to detect the duplication and its extent [4].
Differential diagnosis
Occurrence of double supernumerary isodicentric chro-
mosomes derived from 15, resulting in partial hexasomy
of the maternally inherited PWS/ASCR, has also been
reported [4,49]. This disorder is, as well, associated with
an abnormal phenotype, including severe psychomotor
delay, hypotonia, joint hyperlaxity, brachycephaly, facial
dysmorphisms, and small hands and feet [38].
Hypotonia in infancy can be severe and may lead to
genetic evaluation for PWS, showing the idic(15) chromo-
some [21].
Genetic counseling
Large SMC(15) (supernumerary marker chromosome),
which include PWS/ASCR, or idic(15), are nearly always
sporadic.
Antenatal diagnosis
Prenatal diagnosis is possible, and has frequently been
reported [50].
Cells obtained by chorionic villus sampling (CVS) at
approximately 12 weeks' gestation, or amniocentesis, usu-
ally performed at approximately 15–18 weeks' gestation,
can be analyzed by a combination of cytogenetic (G-C-
banding, FISH), and molecular (methylation analysis)
methods.
Management
The management of inv dup (15) includes a comprehen-
sive neurophysiologic and developmental evaluation.
A waking/sleeping polygraphic-video-EEG study is recom-
mended in infancy and childhood in order to achieve the
best characterization of the seizures. This is of the utmost
importance for the first choice pharmacotherapy. In the
Table 1: Frequency of the main clinical characteristics of inv dup(15) or idic(15) syndrome
Exceeding 75% From 25% to 50% Below 25%
Hypotonia, lax ligaments Brain abnormalities Congenital heart defects
Developmental delay/Intellectual disability Genitourinary tract defects Microcephaly
Autistic behavior Growth retardation
Epilepsy
Minor dysmorphic features (mainly involving the face)Orphanet Journal of Rare Diseases 2008, 3:30 http://www.ojrd.com/content/3/1/30
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author's experience, the most helpful drug treatment is
represented by the association of valproate (VPA), and/or
carbamazepine (CBZ) with lamotrigine (LTG). VPA is the
first choice drug in those cases in whom the onset seizures
are represented by atypical absences, whereas CBZ can be
chosen whenever tonic seizures are the onset ones and the
most frequent. Regular follow-up of seizure status and
pharmacotherapy is essential.
A thorough developmental evaluation by a specialist
should be performed at intervals appropriate for planning
of early intervention, including physical, occupational
and speech therapies, and for educational and vocational
planning.
Prognosis
Survival is not significantly reduced. However, very
recently there has been the sudden, unexpected, and as yet
unexplained death of six seemingly healthy young indi-
viduals with chromosome 15q duplication syndrome.
Research is underway to investigate this phenomenon
[51].
A global evolution of the adaptive behavior, social inter-
action, and fine and gross motor skills may be seen over
time, associated with an improvement in the communica-
tive abilities and verbal comprehension, and a decreased
occurrence of withdrawal behavior (personal observa-
tion).
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